Urinary Galectin-3 as a Novel Biomarker for the Prediction of Renal Fibrosis and Kidney Disease Progression

Plasma galectin-3 (Gal-3) is associated with organ fibrosis, but whether urinary Gal-3 is a potential biomarker of kidney disease progression has never been explored. Between 2018 and 2021, we prospectively enrolled 280 patients who underwent renal biopsy and were divided into three groups based on...

Descripción completa

Detalles Bibliográficos
Autores principales: Ou, Shuo-Ming, Tsai, Ming-Tsun, Chen, Huan-Yuan, Li, Fu-An, Lee, Kuo-Hua, Tseng, Wei-Cheng, Chang, Fu-Pang, Lin, Yao-Ping, Yang, Ruey-Bing, Tarng, Der-Cherng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945118/
https://www.ncbi.nlm.nih.gov/pubmed/35327386
http://dx.doi.org/10.3390/biomedicines10030585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945118/
https://www.ncbi.nlm.nih.gov/pubmed/35327386
http://dx.doi.org/10.3390/biomedicines10030585

Ejemplares similares